Repurposed drug shows promise for treating COVID-19 inflammation
Yale clinicians report promising results after treating COVID-19 patients at Yale New Haven Hospital (YNHH) with a drug that reduces hyperinflammation in cancer patients undergoing immunotherapy.
Jun 19, 2020
0
56